[AIDS FOR ASSESSING DIOXIN] NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[AIDS FOR ASSESSING DIOXIN]

Available from National Technical Information Service, Springfield, VA, as NTIS/TIB/A88-80572, 66 p., 1988.. Unique Identifier : AIDSLINE ICDB/89657542
Menzel H; Quecke C; Hessische Landesanstalt fur Umwelt, Wiesbaden, FRG

Abstract: The danger of dioxin is shown, on the one hand, by its acute toxicity (1/10 of a million of a gram will cause the death of a guinea pig) and on the other hand, by its carcinogenic effect, the damage to future generations and the destruction or weakening of the body's defenses. A precise survey on this is first concerned with the assessment of the danger based on toxicological investigations (carcinogenic effect on animals and on human beings; determining the acceptable daily dose for human beings), in order to give individual values for 2,3,7,8 TCDD in the following compartments: breathed air, foodstuffs, drinking water, surface water, soil and materials. Finally, there is an evaluation of individual dioxin isomers (2,3,7,8 TCDD as the main substance, taking 8 chlorine isomers into account, transition control).
Keywords: Animal *Carcinogens, Environmental Dioxins/*ADVERSE EFFECTS Dose-Response Relationship, Drug Guinea Pigs Human Maximum Permissible Exposure Level Neoplasms/*CHEMICALLY INDUCED Risk Factors Tetrachlorodibenzodioxin/ADVERSE EFFECTS NONGOVERNMENT REPORTKWDanimalKWDcarcinogens,environmentaldioxins/KWDadverseeffectsdose-responserelationship,drugguineapigshumanmaximumpermissibleexposurelevelneoplasms/KWDchemicallyinducedriskfactorstetrachlorodibenzodioxin/adverseeffectsnongovernmentreport
891230
M89C0824

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .